Pivot Pharma scores ERS Holdings
Pivot Pharma fully acquired California-based ERS Holdings, LLC to monetize their IP in February 2018. ERS has patents for a cannabis oil to powder transformation technology called Ready-To-Infuse-Cannabis (RTIC) which has already received interest from multi-national beer and spirits companies. Pivot has appointed Mr. Patrick J. Rolfes, co-inventor of RTIC, as ERS’ President and as Director of Research and Development in order to develop more cannabis food and drink infusion methods. All patents have been reassigned to Pivot Pharma’s subsidiary Pivot Naturals.
Related Posts
May 20, 2021
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
April 15, 2021
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
April 8, 2021
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…


